Abaco Capital logo

ABA - Abaco Capital Share Price

1.5p 0.0  0.0%

Last Trade - 04/05/18

Sector
Financials
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 1834
Bullish
Bearish
Unlock ABA Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ABA Revenue Unlock ABA Revenue

Net Income

ABA Net Income Unlock ABA Revenue

Normalised EPS

ABA Normalised EPS Unlock ABA Revenue

PE Ratio Range

ABA PE Ratio Range Unlock ABA Revenue

Dividend Yield Range

ABA Dividend Yield Range Unlock ABA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ABA EPS Forecasts Unlock ABA Revenue
Profile Summary

Abaco Capital plc, formerly Oxford Pharmascience Group plc, is a United Kingdom-based shell company. The Company is seeking for the investment opportunities in any sector. The Company has no operations.

Directors
Last Annual December 31st, 2017
Last Interim December 31st, 2017
Incorporated October 7, 2009
No. of Shareholders: n/a
No. of Employees: 6
Sector Financials
Industry Holding Companies
Index
Exchange London Stock Exchange
Shares in Issue 1,205,661,619
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ABA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Similar to ABA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.